Clinical Trial Update: Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a reduced-dose unfractionated heparin regimen in patients undergoing PCI for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED